Dimension Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Dimension Capital Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.42M	Hold	27,959	–	–	0.52%	33
2026 Q1	$3.57M	Buy	27,959 +2,633	+10%	+$329K	0.5%	31
2025 Q4	$3.09M	Sell	25,326 -2,290	-8%	-$263K	0.43%	35
2025 Q3	$2.77M	Sell	27,616 -306	-1%	-$27.6K	0.4%	36
2025 Q2	$2.32M	Hold	27,922	–	–	0.36%	36
2025 Q1	$2.26M	Buy	27,922 +10,635	+62%	+$951K	0.4%	28
2024 Q4	$1.56M	Buy	17,287 +767	+5%	+$74.3K	0.25%	37
2024 Q3	$1.63M	Buy	16,520 +1,209	+8%	+$119K	0.3%	36
2024 Q2	$1.42M	Buy	15,311 +3,396	+29%	+$304K	0.29%	35
2024 Q1	$1.13M	Buy	11,915 +2,827	+31%	+$262K	0.23%	39
2023 Q4	$811K	Hold	9,088	–	–	0.17%	44
2023 Q3	$664K	Hold	9,088	–	–	0.16%	37
2023 Q2	$756K	Hold	9,088	–	–	0.16%	43
2023 Q1	$693K	Hold	9,088	–	–	0.16%	45
2022 Q4	$754K	Sell	9,088 -11,738	-56%	-$950K	0.18%	45
2022 Q3	$1.65M	Sell	20,826 -3,518	-14%	-$297K	0.4%	31
2022 Q2	$1.81M	Buy	24,344 +3,069	+14%	+$230K	0.41%	29
2022 Q1	$1.91M	Buy	+21,275	New	+$1.96M	0.36%	34

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Dimension Capital Management's XBI Position: Q2 2026 in Review

Dimension Capital Management held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 27,959 shares worth $4.42M. The position accounts for 0.52% of the portfolio, ranked #33.

Dimension Capital Management first reported a position in XBI in Q1 2022 and has held it in 18 quarters since. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Dimension Capital Management held 27,959 shares of State Street SPDR S&P Biotech ETF worth $4.42M as of Q2 2026.
Dimension Capital Management left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
State Street SPDR S&P Biotech ETF made up 0.52% of Dimension Capital Management's portfolio in Q2 2026, its #33 holding.
Dimension Capital Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2022 and has held it in 18 quarters since.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Dimension Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.